Ledger.Open graph →
SEC Form D · filed December 7, 2021

Saliogen Therapeutics, Inc

Offering
$125.0M
Sold
$74.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jason Baumgartner · Branford, CTDirectorPatrick Horan · NEW YORK, NYDirectorChris Darland · NEW YORK, NYExec · DirectorYechuan Zhang · London, United KingdomDirectorDevin Carty · Branford, CTExec · DirectorCedarview GP, LLC · Woodmere, NYExec · DirectorCraig Gordon · Cambridge, MADirectorSukumar Nagendran · Cambridge, MADirectorJoseph Higgins · Cambridge, MAExec · DirectorRichard Skeet · London, United KingdomExec · DirectorNicholas Jackson · NEW YORK, NYDirectorMichael P. Brown Ii · Austin, TXDirectorRaymond Tabibiazar · Cambridge, MAExec · DirectorSean Stalfort · Cambridge, MADirectorTamanna Bembenek, Ph.D · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗